1. Potential role of lipoxin in the management of COVID-19: a narrative review.
- Author
-
Batiha, Gaber El-Saber, Al-Gareeb, Ali I., Elekhnawy, Engy, and Al-kuraishy, Hayder M.
- Subjects
- *
COVID-19 , *UNSATURATED fatty acids , *ARACHIDONIC acid , *CYTOKINE release syndrome - Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection leads to the development of coronavirus disease 2019 (COVID-19), which causes endothelial dysfunction (ED), oxidative stress (OS), and inflammatory disorders. These changes cause hypoxia and cytokine storm with the development of cardio-pulmonary complications. Bioactive lipids and other polyunsaturated fatty acids participate in a vital role in the SARS-CoV-2 infection process. One of these mediators is the anti-inflammatory compound, lipoxin (LX). LXs are produced from arachidonic acid (AA) by collaboration between 5-lipoxygenase (5-LO) and 12–15 LO during cell interactions. Thus, our goal was to review the probable role of LXs in COVID-19 regarding the effects of LXs on the inflammatory signaling pathways that are linked with COVID-19 pathogenesis and complications. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF